Schott Pharma falls after mid-term guidance cut

SCHOTT Pharma AG & Co KgaA

05/12/2025 07:34

** Shares of SCHOTT Pharma1SXP.DE fall 4.3% in early Frankfurt trade after the German medical equipment supplier cut its mid-term guidance

** The company reduced average revenue growth expectations for 2027-29 to 6-8% from above 10%

** SCHOTT Pharma now also expects an EBITDA margin towards 30% vs previous expectation of a percentage in the low 30s

** A local trader says that the lowered mid-term guidance should clearly weigh on shares

** SCHOTT Pharma is the biggest faller in early trading on the German small-cap index .SDAXi

(Reporting by Simon Ferdinand Eibach)

((Simonferdinand.eibach@thomsonreuters.com))